DeClerck YA - Search Results

1

Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases.

Chantrain CF, Henriet P, Jodele S, Emonard H, Feron O, Courtoy PJ, DeClerck YA, Marbaix E. Chantrain CF, et al. Among authors: declerck ya. Eur J Cancer. 2006 Feb;42(3):310-8. doi: 10.1016/j.ejca.2005.11.010. Epub 2006 Jan 10. Eur J Cancer. 2006. PMID: 16406506 Review.

2

Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment.

Chantrain CF, Shimada H, Jodele S, Groshen S, Ye W, Shalinsky DR, Werb Z, Coussens LM, DeClerck YA. Chantrain CF, et al. Among authors: declerck ya. Cancer Res. 2004 Mar 1;64(5):1675-86. doi: 10.1158/0008-5472.can-03-0160. Cancer Res. 2004. PMID: 14996727

3

The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent.

Jodele S, Chantrain CF, Blavier L, Lutzko C, Crooks GM, Shimada H, Coussens LM, Declerck YA. Jodele S, et al. Among authors: declerck ya. Cancer Res. 2005 Apr 15;65(8):3200-8. doi: 10.1158/0008-5472.CAN-04-3770. Cancer Res. 2005. PMID: 15833851

4

Bone marrow microenvironment and tumor progression.

Chantrain CF, Feron O, Marbaix E, DeClerck YA. Chantrain CF, et al. Among authors: declerck ya. Cancer Microenviron. 2008 Dec;1(1):23-35. doi: 10.1007/s12307-008-0010-7. Epub 2008 May 7. Cancer Microenviron. 2008. PMID: 19308682 Free PMC article.

5

Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.

Jodele S, Blavier L, Yoon JM, DeClerck YA. Jodele S, et al. Among authors: declerck ya. Cancer Metastasis Rev. 2006 Mar;25(1):35-43. doi: 10.1007/s10555-006-7887-8. Cancer Metastasis Rev. 2006. PMID: 16680570 Review.

6

Tissue inhibitors of matrix metalloproteinases in cancer.

Blavier L, Henriet P, Imren S, Declerck YA. Blavier L, et al. Among authors: declerck ya. Ann N Y Acad Sci. 1999 Jun 30;878:108-19. doi: 10.1111/j.1749-6632.1999.tb07677.x. Ann N Y Acad Sci. 1999. PMID: 10415723 Review.

7

The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model.

Ferrario A, Chantrain CF, von Tiehl K, Buckley S, Rucker N, Shalinsky DR, Shimada H, DeClerck YA, Gomer CJ. Ferrario A, et al. Among authors: declerck ya. Cancer Res. 2004 Apr 1;64(7):2328-32. doi: 10.1158/0008-5472.can-04-0071. Cancer Res. 2004. PMID: 15059880

8

Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation.

Henriet P, Blavier L, Declerck YA. Henriet P, et al. Among authors: declerck ya. APMIS. 1999 Jan;107(1):111-9. doi: 10.1111/j.1699-0463.1999.tb01533.x. APMIS. 1999. PMID: 10190287

9

Computerized quantification of tissue vascularization using high-resolution slide scanning of whole tumor sections.

Chantrain CF, DeClerck YA, Groshen S, McNamara G. Chantrain CF, et al. Among authors: declerck ya. J Histochem Cytochem. 2003 Feb;51(2):151-8. doi: 10.1177/002215540305100203. J Histochem Cytochem. 2003. PMID: 12533523

10

Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1.

Henriet P, Zhong ZD, Brooks PC, Weinberg KI, DeClerck YA. Henriet P, et al. Among authors: declerck ya. Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10026-31. doi: 10.1073/pnas.170290997. Proc Natl Acad Sci U S A. 2000. PMID: 10944199 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page